Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular ATP-dependent processes via the adenylate energy pool refer to the integrated network of biochemical reactions that utilize the chemical energy stored in adenosine triphosphate (ATP) to drive essential cellular functions. This system is governed by the adenylate energy charge, a ratio of ATP, ADP, and AMP concentrations that serves as a fundamental indicator of cellular energy status (Atkinson, 1968, Biochemistry). It is not a single molecular target but a physiological framework encompassing thousands of enzymes, including ATPases, kinases, and ligases, which facilitate processes such as active transport, biosynthesis, and mechanical work (StatPearls, 2023). The primary sensor for this pool is the AMP-activated protein kinase (AMPK), which monitors the AMP:ATP ratio and coordinates a metabolic switch from energy-consuming anabolic pathways to energy-producing catabolic pathways (Hardie, 2011, Genes & Development). Dysregulation of the adenylate pool is implicated in a wide range of pathologies, including cardiovascular ischemia, where ATP depletion leads to cell death, and cancer, where the Warburg effect alters energy flux to support rapid proliferation (Vander Heiden et al., 2009, Science). While the pool itself is not a discrete drug target, many therapeutic agents like metformin indirectly modulate it by inhibiting mitochondrial respiration, thereby increasing the AMP:ATP ratio to activate AMPK for the treatment of metabolic disorders (Xiao et al., 2011, Nature).
Modulation of the cellular ATP/AMP ratio, typically through the inhibition of mitochondrial complex I or glycolysis, which leads to the activation of the energy sensor AMP-activated protein kinase (AMPK) (Hardie, 2011, Genes & Development).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular ATP-dependent processes via adenylate energy pool.